Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer

Cancer Research

Volumn 68, Issue 16, 2008, Pages 6770-6778

  Pallante, Pierlorenzo ^a,b   Federico, Antonella ^b   Berlingieri, Maria Teresa ^a   Bianco, Mimma ^a   Ferraro, Angelo ^b   Forzati, Floriana ^a   Iaccarino, Antonino ^a   Russo, Maria ^a   Pierantoni, Giovanna Maria ^a   Leone, Vincenza ^b   Sacchetti, Silvana ^b   Troncone, Giancarlo ^a,b   Santoro, Massimo ^a,b   Fusco, Alfredo ^a,b,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^c European School of Molecular Medicine SEMM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC CARCINOMA; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CANCER PATIENT; CANCER STAGING; CBX7 GENE; CELL CYCLE G1 PHASE; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LOSS; GENETIC CORRELATION; GROWTH RATE; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TISSUE SECTION; TUMOR GENE; ADENOCARCINOMA; ADENOVIRUS; ANIMAL; CARCINOMA; CELL PROLIFERATION; CHROMOSOME 22; CLONOGENIC ASSAY; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOSITY LOSS; METABOLISM; MOUSE; NUDE MOUSE; PAPILLARY CARCINOMA; PATHOLOGY; THYROID GLAND; THYROID TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

CBX7 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA; REPRESSOR PROTEIN; RNA;

ADENOCARCINOMA, FOLLICULAR; ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CARCINOMA; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 22; COLONY-FORMING UNITS ASSAY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOSS OF HETEROZYGOSITY; MICE; MICE, NUDE; RATS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; THYROID GLAND; THYROID NEOPLASMS;

EID: 53049103365     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-0695     Document Type: Article

References (45)

1. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumours: a commentary on the second edition. Cancer 1989;63:908-11.
2. Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006;6:292-306.
3. Nardone HC, Ziober AF, LiVolsi VA, et al. c-Met expression in tall cell variant papillary carcinoma of the thyroid. Cancer 2003;98:1386-93.
4. Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer 2005;12:245-62.
5. Pierotti MA, Greco A. Oncogenic rearrangements of the NTRK1/NGF receptor. Cancer Lett 2006;232:90-8.
6. Di Renzo ME, Olivero M, Ferro S, et al. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 1992;7:2549-53.
7. Suarez HG, du Villard JA, Severino M, et al. Presence of mutations in all three ras genes in human thyroid tumors. Oncogene 1990;5:565-70.
8. Kroll TG, Sarraf P, Pecciarini L, et al. PAX-8-PPARγ1 fusion oncogene in human thyroid carcinoma. Science 2000;289:1357-60.
9. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH, Koeffler HP. High prevalence of mutations of p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 1993;91:179-84.
10. Paro R, Hogness DS. The Polycomb protein shares a homologous domain with a heterochromatin-associated protein of Drosophila. Proc Natl Acad Sci U S A 1991;88:263-67.
11. Gil J, Bernard D, Martinez D, Beach D. Polycomb CBX7 has a unifying role in cellular lifespan. Nat Cell Biol 2004;6:67-72.
12. Bernard D, Martinez-Leal JF, Rizzo S, et al. CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. Oncogene 2005;24:5543-51.
13. Bernstein E, Duncan EM, Masui O, Gil J, Heard E, Allis CD. Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin. Mol Cell Biol 2006;26:2560-69.
14. Pallante P, Berlingieri MT, Troncone G, et al. UbcHIO overexpression may represent a marker of anaplastic thyroid carcinomas. Br J Cancer 2005;93:464-71.
15. Curcio F, Ambesi-Impiombato FS, Perrella G, Coon HG. Long-term culture and functional characterization of follicular cells from adult normal human thyroids. Proc Natl Acad Sci U S A 1994;91:9004-8.
16. Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Greco M, Vecchio G. One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol Cell Biol 1987;7:3365-70.
17. Ambesi-Impiombato FS, Parks LA, Coon HG. Culture of hormone dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci U S A 1980; 77:3455-9.
18. Berlingieri MT, Portella G, Greco M, Santoro M, Fusco A. Cooperation between the polyomavirus middle-T-antigen gene and the human c-myc oncogene in a rat thyroid epithelial differentiated cell line: model of in vitro progression. Mol Cell Biol 1988;8:2261-6.
19. Berlingieri MT, Santoro M, Battaglia C, Greco M, Fusco A. The Adenovirus E1A gene blocks the differentiation of a thyroid epithelial cell line, however the neoplastic phenotype is achieved only after cooperation with other oncogenes. Oncogene 1993;8:249-55.
20. Santoro M, Melillo RM, Grieco M, Berlingieri MT, Vecchio G, Fusco A. The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. Cell Growth Differ 1993;4:77-84.
21. Berlingieri MT, Manfioletti G, Santoro M, et al. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 1995;15:1545-53.
22. Fusco A, Portella G, Di Fiore PP, et al. A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern. J Virol 1985;56:284-92.
23. Berlingieri MT, Pierantoni GM, Giancotti V, Santoro M, Fusco A. Thyroid cell transformation requires the expression of the HMGA1 proteins. Oncogene 2002;21:2971-80.
24. Zeppa P, Vetrani A, Marino M, et al. Fine needle aspiration of medullary thyroid carcinoma: a review of 18 cases. Cytopathology 1990;1:35-44.
25. Troncone G, Fulciniti F, Zeppa P, Vetrani A, Caleo A, Palombini L. Cyclin-dependent kinase inhibitor p27(Kipl) expression in thyroid cells obtained by fine needle aspiration biopsy: a preliminary report Diagn Cytopathol 2000;23:77-81.
26. Van Staveren WC, Solís DW, Delys L, et al. Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype. Cancer Res 2007;67:8113-20.
27. Wild A, Langer P, Celik I, Chaloupka B, Bartsch DK. Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions. Eur J Endocrinol 2002; 147:507-13.
28. Iida A, Kurose K, Isobe R, et al. Mapping of a new target region of allelic loss to a 2-cM interval at 22ql3.1 in primary breast cancer. Genes Chromosomes Cancer 1998;21:108-12.
29. Russell JP, Powell DJ, Cunnane M, et al. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium. Oncogene 2000;19:5729-35.
30. Powell DJ, Jr., Russell J, Nibu K, et al. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer Res 1998;58:5523-8.
31. Vitagliano D, Portella G, Troncone G, et al. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. Oncogene 2006;25:5467-74.
32. Ledent C, Dumont J, Vassart G, Parmentier M. Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice. Endocrinology 1991;129:1391-401.
33. Scott CL, Gil J, Hernando E, et al. Role of the chromobox protein CBX7 in lymphomagenesis. Proc Natl Acad Sci U S A 2007;104:5389-94.
34. Barroeta JE, Baloch ZW, Lai P, Pasha TL, Zhang PJ, LiVolsi VA. Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and pl6 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis. Endocr Pathol 2006;17:225-34.
35. Ferru A, Fromont G, Gibelin H, et al. The status of CDKN2A α (p16INK4A) and β (pl4ARF) transcripts in thyroid tumour progression. Br J Cancer 2006;95:1670-7.
36. Swarbrick A, Roy E, Allen T, Bishop JM. Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response. Proc Natl Acad Sci U S A 2008;105:5402-7.
37. Delys L, Detours V, Franc B, et al. Gene expression and the biological phenotype of papillary thyroid carcinomas. Oncogene 2007;26:7894-903.
38. Richter H, Braselmann H, Hieber L, et al. Chromosomal imbalances in post-Chernobyl thyroid tumors. Thyroid 2004;14:1061-4.
39. Fusco A, Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer 2007;7:899-910.
40. Wood LJ, Maher JF, Bunton TE, Resar LM. The oncogenic properties of the HMG-I gene family. Cancer Res 2000:60:4256-61.
41. Baldassarre G, Fedele M, Battista S, et al. Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci U S A 2001;98:7970-5.
42. Fedele M, Pentimalli F, Baldassarre G, et al. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene 2005;24:3427-35.
43. Fedele M, Fidanza V, Battista S, et al. Haploinsufficiency of the Hmgal gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res 2006:66:2536-43.
44. Johnson DG, Degregori J. Putting the oncogenic and tumor suppressive activities of E2F into context. Curr Mol Med 2006;6:731-8.
45. Suarez-Merino B, Hubank M, Revesz T, et al. Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3. Neuro-oncol 2005;7:20-31.